These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11166892)

  • 1. Electric pulses increase the immunogenicity of an influenza DNA vaccine injected intramuscularly in the mouse.
    Bachy M; Boudet F; Bureau M; Girerd-Chambaz Y; Wils P; Scherman D; Meric C
    Vaccine; 2001 Feb; 19(13-14):1688-93. PubMed ID: 11166892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against influenza virus infection in mice immunized by administration of hemagglutinin-expressing DNAs with electroporation.
    Kadowaki S; Chen Z; Asanuma H; Aizawa C; Kurata T; Tamura S
    Vaccine; 2000 Jun; 18(25):2779-88. PubMed ID: 10812219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with a DNA chimeric molecule encoding a hemagglutinin peptide and a scFv CD21-specific antibody fragment induces long-lasting IgM and CTL responses to influenza virus.
    Ivanovska N; Tchorbanov A; Prechl J; Maximova V; Voynova E; Vassilev TL
    Vaccine; 2006 Mar; 24(11):1830-7. PubMed ID: 16289708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased immunogenicity of avian influenza DNA vaccine delivered to the skin using a microneedle patch.
    Kim YC; Song JM; Lipatov AS; Choi SO; Lee JW; Donis RO; Compans RW; Kang SM; Prausnitz MR
    Eur J Pharm Biopharm; 2012 Jun; 81(2):239-47. PubMed ID: 22504442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Humoral Responses Induced by an H7N9 Influenza Virus-Like Particle Vaccine in BALB/C Mice.
    Zhang L; Lu J; Chen Y; Shi F; Yu H; Huang C; Cui L; Shi Z; Jiao Y; Hu Y
    Viruses; 2015 Aug; 7(8):4369-84. PubMed ID: 26248076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza.
    Huber VC; McKeon RM; Brackin MN; Miller LA; Keating R; Brown SA; Makarova N; Perez DR; Macdonald GH; McCullers JA
    Clin Vaccine Immunol; 2006 Sep; 13(9):981-90. PubMed ID: 16960108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin.
    Smith LR; Wloch MK; Ye M; Reyes LR; Boutsaboualoy S; Dunne CE; Chaplin JA; Rusalov D; Rolland AP; Fisher CL; Al-Ibrahim MS; Kabongo ML; Steigbigel R; Belshe RB; Kitt ER; Chu AH; Moss RB
    Vaccine; 2010 Mar; 28(13):2565-72. PubMed ID: 20117262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA vaccination in the skin using microneedles improves protection against influenza.
    Song JM; Kim YC; O E; Compans RW; Prausnitz MR; Kang SM
    Mol Ther; 2012 Jul; 20(7):1472-80. PubMed ID: 22508490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent adjuvant effects of novel NKT stimulatory glycolipids on hemagglutinin based DNA vaccine for H5N1 influenza virus.
    Hung JT; Tsai YC; Lin WD; Jan JT; Lin KH; Huang JR; Cheng JY; Chen MW; Wong CH; Yu AL
    Antiviral Res; 2014 Jul; 107():110-8. PubMed ID: 24786174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with a low dose of hemagglutinin-encoding plasmid protects against 2009 H1N1 pandemic influenza virus in mice.
    Fang J; Chen Z; Liu X; Li H; Wang J; Shen X; Chen W; Liu Y; Wang Y; Zhao P; Qi Z
    J Virol Methods; 2011 May; 173(2):314-9. PubMed ID: 21392537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant use of the NKT cell agonist alpha-galactosylceramide leads to enhancement of M2-based DNA vaccine immunogenicity and protective immunity against influenza A virus.
    Fotouhi F; Shaffifar M; Farahmand B; Shirian S; Saeidi M; Tabarraei A; Gorji A; Ghaemi A
    Arch Virol; 2017 May; 162(5):1251-1260. PubMed ID: 28120096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice.
    Wack A; Baudner BC; Hilbert AK; Manini I; Nuti S; Tavarini S; Scheffczik H; Ugozzoli M; Singh M; Kazzaz J; Montomoli E; Del Giudice G; Rappuoli R; O'Hagan DT
    Vaccine; 2008 Jan; 26(4):552-61. PubMed ID: 18162266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of Local Secretory IgA and Multifunctional CD4⁺ T-helper Cells Following Intranasal Immunization with a H5N1 Whole Inactivated Influenza Virus Vaccine in BALB/c Mice.
    Trondsen M; Aqrawi LA; Zhou F; Pedersen G; Trieu MC; Zhou P; Cox RJ
    Scand J Immunol; 2015 May; 81(5):305-17. PubMed ID: 25737202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality and kinetics of the antibody response in mice after three different low-dose influenza virus vaccination strategies.
    Hauge S; Madhun A; Cox RJ; Haaheim LR
    Clin Vaccine Immunol; 2007 Aug; 14(8):978-83. PubMed ID: 17596426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baculovirus vector as an avian influenza vaccine: hemagglutinin expression and presentation augment the vaccine immunogenicity.
    Chen CY; Lin SY; Cheng MC; Tsai CP; Hung CL; Lo KW; Hwang Y; Hu YC
    J Biotechnol; 2013 Mar; 164(1):143-50. PubMed ID: 23313887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization of non-human primates with DNA vaccines.
    Liu MA; McClements W; Ulmer JB; Shiver J; Donnelly J
    Vaccine; 1997 Jun; 15(8):909-12. PubMed ID: 9234545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant effect of CD40 on H5N1 DNA vaccine in mice.
    Chen Q; Zhu G; Wang R; Zhang J; He G
    Arch Virol; 2014 Jun; 159(6):1359-64. PubMed ID: 24357081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for improving the efficacy of a H6 subtype avian influenza DNA vaccine in chickens.
    Shan S; Jiang Y; Bu Z; Ellis T; Zeng X; Edwards J; Tian G; Li Y; Ge J; Chen H; Fenwick S
    J Virol Methods; 2011 May; 173(2):220-6. PubMed ID: 21333689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intradermal DNA immunization by using jet-injectors in mice and monkeys.
    Haensler J; Verdelet C; Sanchez V; Girerd-Chambaz Y; Bonnin A; Trannoy E; Krishnan S; Meulien P
    Vaccine; 1999 Feb; 17(7-8):628-38. PubMed ID: 10067667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.
    Wang D; Christopher ME; Nagata LP; Zabielski MA; Li H; Wong JP; Samuel J
    J Clin Virol; 2004 Dec; 31 Suppl 1():S99-106. PubMed ID: 15567101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.